These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 969073)

  • 1. Prostatic carcinoma. relationship between primary tumor, histologic grade, and response to chemotherapy.
    Gibbons RP; Scott WW; Johnson DE; Prout GR; Schmidt JD; Murphy GP
    Urology; 1976 Sep; 8(3):222-6. PubMed ID: 969073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate.
    Scott WW; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Saroff J; Murphy GP
    J Urol; 1976 Aug; 116(2):211-3. PubMed ID: 950706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate.
    Scott WW; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Saroff J; Murphy GP
    Trans Am Assoc Genitourin Surg; 1976; 68():24-8. PubMed ID: 1030548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotherapy of prostatic carcinoma.
    Beckley S; Wajsman Z; Slack N; Mittelman A; Murphy GP
    Scand J Urol Nephrol Suppl; 1980; 55():151-62. PubMed ID: 6938019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
    Collier D; Soloway MS
    Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
    Herr HW
    J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
    Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP
    Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
    Smalley RV; Bartolucci AA; Hemstreet G; Hester M
    J Urol; 1981 Feb; 125(2):191-5. PubMed ID: 7206052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study.
    Scott WW; Johnson DE; Schmidt JE; Gibbons RP; Prout GR; Joiner JR; Saroff J; Murphy GP
    J Urol; 1975 Dec; 114(6):909-11. PubMed ID: 1104900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil.
    Laurie JA; Hahn RG; Therneau TM; Patel SR; Mailliard JA; Windschitl HE; Twito DI; Morton RF; Krook JE
    Cancer; 1992 Mar; 69(6):1440-4. PubMed ID: 1540881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
    Borgmann V; al-Abadi H; Nagel R
    Am J Clin Oncol; 1988; 11 Suppl 1():S19-28. PubMed ID: 2968759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
    Eagan RT; Utz DC; Myers RP; Furlow WL
    Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advanced cancer of the prostate: chemotherapy].
    Garcia-Giralt E; Palangie T; Dorval T; Jouve M; Pouillart P
    Bull Cancer; 1986; 73(1):68-73. PubMed ID: 3779125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of advanced prostatic cancer. Evaluation of response parameters.
    Schmidt JD; Gibbons RP; Johnson DE; Prout GR; Scott WW; Murphy GP
    Urology; 1976 Jun; 7(6):602-10. PubMed ID: 936381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential polychemotherapy for advanced prostatic carcinoma. A preliminary cooperative study on 30 patients.
    Lachand AT; Garcia-Giralt E; Auvert J; Juraschek F; Mennecier P; Pallangie T; Moustafa T
    Eur Urol; 1979; 5(4):250-1. PubMed ID: 436871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orimeten in the treatment of advanced carcinoma of the prostate].
    Vachalovský V; Vomácka V
    Rozhl Chir; 1989 Apr; 68(4):268-71. PubMed ID: 2501877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer.
    Murphy GP; Huben RP; Priore R
    Urology; 1986 Jul; 28(1):36-40. PubMed ID: 3523938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prelinimary report on combination therapy for advanced prostatic cancer.
    Merrin C
    Cancer Treat Rep; 1977; 61(2):313-5. PubMed ID: 559544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.